Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, Pre-B-Cell

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Leukemia, Pre-B-Cell in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, M1
Zou, X1
Lu, L1
Juarez, J1
Baraz, R1
Gaundar, S1
Bradstock, K1
Bendall, L1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, Pre-B-Cell

ArticleYear
Potential efficacy and prognosis of silencing the CRLF2‑mediated AKT/mTOR pathway in pediatric acute B‑cell lymphoblastic leukemia.
    Oncology reports, 2019, Volume: 41, Issue:2

    Topics: Apoptosis; Bone Marrow; Cell Movement; Child; Chromones; Female; Gene Knockdown Techniques; Humans;

2019
Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia.
    Haematologica, 2007, Volume: 92, Issue:4

    Topics: Adolescent; Apoptosis; B-Lymphocytes; Blood Cells; Bone Marrow Cells; Cell Division; Cell Survival;

2007